Pacific Edge surges; NZX 50 falls

Pacific Edge surges; NZX 50 falls
Dan Brunskill
Shares in cancer diagnostic firm Pacific Edge skyrocketed, climbing more than 20% on a deal with a large US insurer, even as the wider share market edged lower.The S&P/NZX 50 Index fell 58.25 points, or 0.5%, to 12,574.35. Within the index, 23 stocks fell, 21 rose, and six were unchanged. Turnover was $203.1 million.Pacific Edge was the best performer by a wide margin. Investors added $100m, or more than a fifth, to the cancer diagnostic firm’s market capitalisation after its Cxbladder test was approved by the biggest healthcare group...

More Markets

NZ sharemarket rocked by US inflation data
Markets Market close

NZ sharemarket rocked by US inflation data

The S&P/NZX 50 Index closed at 141.34 points or 1.18%.

Duncan Bridgeman 26 Apr 2024
Australian company seeks A$30m for Otago gold mining
Markets

Australian company seeks A$30m for Otago gold mining

Santana Minerals wants to 'rapidly advance' a South Island gold mining project.

John Anthony 26 Apr 2024
NZ sharemarket celebrates highest single-day rise in over five months
Markets Market close

NZ sharemarket celebrates highest single-day rise in over five months

The S&P/NZX 50 Index closed at 11,946.43, increasing 143.15 points or 1.21%.

Graham Skellern 24 Apr 2024
'Serious compliance breaches' in NZ sharemarket
Markets

'Serious compliance breaches' in NZ sharemarket

Seven matters were referred to the NZ Markets Disciplinary Tribunal last year.

Murray Jones 24 Apr 2024